Analyst Activity – Cowen Reiterates Hold on RETA – Reata Pharmaceuticals (NASDAQ:RETA)

ME Staff
-
0

Analyst Ratings For RETA – Reata Pharmaceuticals (NASDAQ:RETA)

Today, Cowen reiterated its Hold rating on RETA – Reata Pharmaceuticals (NASDAQ:RETA).

Some recent analyst ratings include

  • 4/9/2018-Cowen Reiterated Rating of Hold.
  • 10/24/2017-Robert W. Baird Reiterated Rating of Buy.
  • 10/6/2017-Jefferies Group Reiterated Rating of Buy.
  • 9/13/2017-Leerink Swann initiated coverage with a Outperform rating.
  • 8/23/2017-Citigroup Reiterated Rating of Buy.
  • 7/26/2017-Ladenburg Thalmann Reiterated Rating of Buy.
  • 7/25/2017-Stifel Nicolaus Reiterated Rating of Buy.

Recent Insider Trading Activity For RETA – Reata Pharmaceuticals (NASDAQ:RETA)
RETA – Reata Pharmaceuticals (NASDAQ:RETA) has insider ownership of 44.00% and institutional ownership of 49.26%.

  • On 12/29/2017 James W Traweek Jr, Major Shareholder, bought 17,000 with an average share price of $28.47 per share and the total transaction amounting to $483,990.00.
  • On 12/29/2017 R Kent Mcgaughy Jr, Director, bought 17,000 with an average share price of $28.47 per share and the total transaction amounting to $483,990.00.
  • On 12/28/2017 James W Traweek Jr, Major Shareholder, bought 27,200 with an average share price of $25.93 per share and the total transaction amounting to $705,296.00.
  • On 12/27/2017 R Kent Mcgaughy Jr, Director, bought 15,000 with an average share price of $25.83 per share and the total transaction amounting to $387,450.00.
  • On 12/26/2017 James W Traweek Jr, Major Shareholder, bought 12,000 with an average share price of $26.06 per share and the total transaction amounting to $312,720.00.
  • On 12/14/2017 Cpmg Inc, Director, bought 200,000 with an average share price of $24.79 per share and the total transaction amounting to $4,958,000.00.
  • On 12/13/2017 James W Traweek Jr, Major Shareholder, bought 121,725 with an average share price of $24.88 per share and the total transaction amounting to $3,028,518.00.

Recent Trading Activity for RETA – Reata Pharmaceuticals (NASDAQ:RETA)
Shares of RETA – Reata Pharmaceuticals closed the previous trading session at 19.87 down -0.07 0.35% with 19.81999969482422 shares trading hands.